SCARLETRED

... is an international Dermatology Startup aiming on to generate novel products for highly demanded applications in the digital analysis and therapeutic treatment of skin diseases.

Company product and R&D portfolio

- SCARLETRED®Vision: The patented mobile medical device system enables objective skin documentation and analysis in (pre-)clinical trials and in skin care industry; see product @ www.scarletredvision.com

- Superoxide Dismutase: The anti-inflammatory acting biologics rhSOD is under clinical development to treat acute and non healing wounds in the orphan disease Epidermolysis bullosa (Butterfly Children).

SCARLETRED Holding GmbH
Campus-Vienna-Biocenter 5
1030 Vienna
Austria
Map

Contact
Harald SCHNIDAR, PhD, MBA
T +43 (0)664 410 9404 office@scarletred.at

www.scarletred.at

Gallery